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Abstract
Background: In Alzheimer's disease (AD) research patients are usually recruited from clinical practice, memory clinics 
or nursing homes. Lack of standardised inclusion and diagnostic criteria is a major concern in current AD studies. The 
aim of the study was to explore whether patient characteristics differ between study samples recruited from general 
practice and from a population based screening by mail within the same geographic areas in rural Northern Norway.
Methods: An interventional study in nine municipalities with 70000 inhabitants was designed. Patients were recruited 
from general practice or by population based screening of cognitive function by mail. We sent a questionnaire to 
11807 individuals ≥ 65 years of age of whom 3767 responded. Among these, 438 individuals whose answers raised a 
suspicion of cognitive impairment were invited to an extended cognitive and clinical examination. Descriptive 
statistics, chi-square, independent sample t-test and analyses of covariance adjusted for possible confounders were 
used.
Results: The final study samples included 100 patients recruited by screening and 87 from general practice. Screening 
through mail recruited younger and more self-reliant male patients with a higher MMSE sum score, whereas older 
women with more severe cognitive impairment were recruited from general practice. Adjustment for age did not alter 
the statistically significant differences of cognitive function, self-reliance and gender distribution between patients 
recruited by screening and from general practice.
Conclusions: Different recruitment procedures of individuals with cognitive impairment provided study samples with 
different demographic characteristics. Initial cognitive screening by mail, preceding extended cognitive testing and 
clinical examination may be a suitable recruitment strategy in studies of early stage AD.
Clinical Registration: ClinicalTrial.gov Identifier: NCT00443014
Background
Alzheimer's disease (AD) constitutes 65 - 70% of all
dementia subtypes. The prevalence is 10% for individuals
65 years and older, encompassing 90% of all AD. The inci-
dence increases from <1% among people 65-69 years of
age to nearly 9% above 85, making AD a major cause of
disability in the elderly [1,2].
Due to the increasing lifespan and the decreasing ratio
of working to retired populations, the social and eco-
nomic burden of neurodegenerative diseases are growing
[3] and may be threatening future welfare and health care.
As a consequence, the European Science and Research
Commission has declared that prevention, early identifi-
cation, and postponement of AD onset should have high
priority. In order to remove or reduce modifiable AD risk
factors, increasing attention to cognitive impairment is
needed within the medical communities, including more
reliable early AD screening tools.
Characteristics of AD study participants depend on
study design, inclusion and diagnostic criteria, recruit-
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ment method and age distribution [4,5]. In clinical trials
AD patients are usually recruited from memory clinics,
hospitals and nursing homes, which makes the studies
prone to selection bias [6]. The heterogeneity of diagnos-
tic criteria and diagnostic tools reinforce these method-
ological challenges [7-10]. As a consequence few
validated screening questionnaires are available and study
comparisons may be hampered due to lack of standard-
ization [11-13]. In a recent population based study
Palmer et al showed that mild cognitive impairment cri-
teria failed to identify individuals with global cognitive
deficits at high risk of AD progression [14].
The impact of different recruitment methods on sam-
ple characteristics is insufficiently examined [15],
whereas studies comparing sample characteristics of indi-
viduals recruited by different methods from the same
population are lacking.
The aim of this paper is to compare clinical and demo-
graphic characteristics in AD individuals recruited from
general practice or by population based screening ques-
tionnaires in the same geographical area.
Methods
Participants
The Dementia Study in Rural Northern Norway planned
to recruit 200 patients with recently diagnosed AD in pri-
mary health care in nine rural municipalities, from Janu-
ary 2006 to December 2007. AD patients were recruited
from general practice (n = 87) and through population
based screening (n = 100) based on the same diagnostic
criteria. Both groups underwent similar cognitive, physi-
cal and laboratory examinations. Inclusion criteria were
individuals aged ≥ 65 years with a MMSE sum score ≥ 10
and ≤ 30 points. Exclusion criteria were delirium and
behavioral disturbances interfering with cognitive and
clinical testing, reluctance to participate, and inability to
understand the purpose of the study, or relatives/caregiv-
ers disapproving participation.
Recruitment by population based screening
Due to a low inclusion rate by general practitioners (GPs)
during the first year, the recruitment method was
extended to comprise a population based screening of
cognitive impairment. An invitation letter enclosing a
questionnaire modified from the Cambridge Examina-
tion for Mental Disorders of the Elderly and Strawbridge
et al [11,12] was sent to 11807 individuals ≥ 65 years of
age in the participating municipalities. The first question
was on participation (Do you want to participate in the
Dementia study?). Four questions covered memory
impairment (Have your memory deteriorated?), visuo-
spatial skills (Do you forget where objects were left?),
speech difficulties (Do you have difficulties to find the
appropriate words?) and activities of daily living (Do you
have difficulties in managing daily activities, which earlier
represented no problem?). An algorithm was designed to
identify individuals at increased risk of having cognitive
impairment (Appendix 1). Based on this, 438 individuals
were invited to an extended cognitive and clinical exami-
nation. A physician with background in geriatric medi-
cine examined the invited individuals, and supervised
and completed the interdisciplinary diagnostic proce-
dures. Among the respondents without self reported cog-
nitive impairment, a randomly selected reference group,
undergoing cognitive testing, was established.
Examination of individuals with memory problems
Prior to study start, GPs and co-workers were trained to
identify and diagnose AD based on the Norwegian guide-
lines [16]. A semi-structured interview of the participants
focused on the onset and the course of cognitive impair-
ment emphasising memory and visuo-spatial distur-
bances, word-finding difficulties, and changes in
executive functions including activities of daily living
(ADL). A family member or a caregiver was encouraged
to add medical data according to the Informant Ques-
tionnaire-Cognitive Decline in the Elderly (IQ-CODE)
[17]. Cognitive function was tested with The Mini Mental
Status Examination (MMSE) [18] and Clock drawing test
[19], and depression was examined with Montgomery
and Aasberg Depression Rating Scale (MADRS) [20].
Neurological examination, blood tests and cerebral com-
puted tomography (CT) were performed to exclude other
causes of dementia but AD.
AD diagnosis
The diagnosis of dementia was set by GPs and discussed
with at least one specialist in geriatric medicine accord-
ing to the ICD-10 criteria [21], AD according to the Sta-
tistical Manual of Mental Disorders fourth edition (DSM-
IV-TR) and probable AD according to National Institute
of Neurological Disorders and Stroke-Alzheimer Disease
and Related Disorders' (NINCDS-ADRDA) criteria [22].
Disagreement or uncertainty about the diagnostic sub-
types regarding 12 patients was solved by consulting a
third specialist in geriatric medicine (MV).
Approvals
The present study is registered as an International Stan-
dard Randomised Controlled Trial within ClinicalTri-
als.gov and approved by the following bodies; The
Regional Committee for Medical Research Ethics in
Northern Norway, The Privacy Ombudsman for
Research, The Directory of Health and Social Welfare
and The Norwegian Medicine Agency including the
EudraCT database (no 2004-002613-37). The Norwegian
Medicine Agency concluded that the study was con-
ducted according to the principles of Good Clinical Prac-
tice. Each participant gave a written informed consent co-Andersen et al. BMC Medical Research Methodology 2010, 10:35
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signed by a spouse, a close relative or a guardian. The
national authorities listed above have approved the con-
sent formula.
This manuscript intends to comply with The CON-
SORT statements and The Uniform Requirements for
Manuscripts Submitted to Biomedical Journals.
Statistics
Descriptive statistics, chi-square, independent sample t-
test, analyses of covariance adjusted for possible con-
founders and multivariable analysis were used with a
two-sided significance level of 5%. SPSS version 15 was
applied for both data management and analysis.
Results
At the end of the inclusion period 87 patients were
recruited from GPs and 100 from population based postal
screening.
Figure 1 describes in detail the outcome of the screen-
ing method. 3767 (31.3%) individuals responded to the
questionnaire, of which 438 persons met the criteria of
self reported cognitive impairment. The cognitive
impairment (CI) group consisted of 292 individuals, but
only 229 individuals underwent cognitive and clinical
examinations due to withdrawals.
Seventy of these had no dementia, 31 had mild cogni-
tive impairment [23] and 15 had cognitive impairment
not due to AD. One hundred and thirteen individuals had
probable AD constituting 49% of the clinically examined
group (n = 229). Thirteen patients with probable AD
withdrew before inclusion. Of those examined, but not
included, 53% were women.
Among 791 individuals who answered "Yes" to question
one (participation) and "No" to the remaining five screen-
ing questions, 500 individuals were randomly selected as
references for the cases. The final reference group (Ref-
group) comprised 199 individuals who underwent cogni-
tive testing. A highly significant difference (p < .001, age
adjusted) was found for MMSE sum score between indi-
viduals with and without self-reported cognitive impair-
ment (CI-group versus Ref-group, Figure 1).
A comparison between the two recruitment methods
(screening versus general practice) (Table 1) revealed that
AD patients recruited by screening more often were male
(p < .001), younger (p = .006), needed less community
support (p < .001), and had a significantly higher MMSE
sum score (p < .001) as compared to those recruited in
general practice, also when adjusting for education and
co-morbidity (p < .001). In a multivariable model, the
estimates remained unchanged. Overall, men were
younger than women (p = .001). Compared to men,
women more frequently lived alone (p < .001, age
adjusted) and more frequently needed support from
community care (p = .04, age adjusted).
Discussion
The main finding of this comparative study was that AD
patient characteristics differed according to recruitment
method. Younger and more often male patients with a
higher MMSE score were recruited by mail as compared
to those recruited in general practice. The estimate of
baseline characteristics remained significantly different
when adjusting for education, coronary heart disease,
hypertension, stroke and diabetes. However, the overall
gender difference in MMSE score turned non-significant
when adjusting for age.
54% of those recruited by population based screening
were men in contrast to only 23% from general practice.
This is in accordance with the findings of Fitzpatrick et al
who reported that men younger than 85 years were more
willing to attend clinical trials dealing with cognitive
function. According to Norwegian Statistics 2008, the
male proportion of the general population above 70 and
80 years were 42% and 35%, respectively [24].
Men recruited by screening were more frequently living
in a relationship in their own home without community
support as compared to men recruited from general prac-
tice. In contrast, female participants were older, less self-
reliant and more likely to live alone. All these factors are
probably highly inter-correlated, partly as a result of dif-
ferent life expectancies for men and women. Living alone
may promote inactivity, isolation and stimulus depriva-
tion, all contributing to dementia progression [25].
Our study confirms that different recruitment methods
in AD research provide samples with different baseline
characteristics. Similar findings have been reported by
Izal et al who emphasises that this could influence the
results significantly [5]. A possible explanation is that a
mailed questionnaire may alert those with a concern of
own memory problems or early stage dementia whereas
routine practice usually diagnoses patients with more
obvious cognitive impairment and loss of compliance and
self-care. According to the algorithm of the screening
program 438 persons were invited to a subsequent cogni-
tive and clinical examination, of which 113 (26%) were
diagnosed with probable AD. In a large population based
screening program conducted by Crews et al, 44.3% of
the participants were recommended a follow-up. Of
these, 24% were referred for objective memory impair-
ment. A number of the patients reported that their GPs
had never adequately assessed their memory complaints
[26].
As for the present screening program, we found that a
selection based on the answers to the postal question-
naire resulted in samples with highly significant differ-
ences in cognitive abilities (p < .001 age adjusted). Among
229 individuals undergoing clinical examination 70 (30%)
had no dementia but had a family member or close rela-
tive with such a diagnosis, which probably contributed toAndersen et al. BMC Medical Research Methodology 2010, 10:35
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Figure 1 Flowchart of population based recruitment to the study by postal screening of cognitive function followed by clinical examina-
tion and testing. *Selection according to a predefined algorithm, Appendix 1. ** Mild cognitive impairment.
Population based screening by 
postal self-administered questionnaire
n=11807
Responders 
n (%)
3767 (31.3)
Excluded by the 
algorithm
n=2538 Self reported cognitive 
impairment invited to 
examination n=438
Cognitive impairment group 
n=292 (CI-group)
MMSE 25.9 ± 3.3
Age 77.6 ± 7.5
Withdrawals for 
undetermined reasons 
n=146
Clinical examination
n=229
Withdrawals for 
undetermined reasons 
n=63
MMSE 25.7 ± 3.7
Age 77.1 ± 7.2
Alzheimer’s disease n=113
No dementia n=70
MMSE 28.3 ± 1.2
Age 74.4 ± 6.5
MCI** n=31
MMSE 27.4 ± 1.4
Age 76.6 ± 6.4
Vascular dementia n=5
Depression n=4 
Parkinson disease n=3
Brain injury n=2
Alcoholic dementia n=1
                In total n=116  
Included to the RCT 
n=100 Withdrawals n=13
MMSE 23.4 ± 4.9
Age 80.1 ± 10.4
No self reported cognitive 
impairment n=791
Randomised sample invited to 
Reference group n=500
Reference group. (Ref-group)
n=199
MMSE 28.6 ± 1.7
Age 73.0 ± 5.5
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a higher level of concern regarding cognitive symptoms.
This group (n = 70) had similar MMSE sum score as the
Ref-group.
Study limitations include the relative low number of
participants in both groups. If screening questions are
imprecise, information bias may threaten the internal
validity of a study like this. We used questions based on
the Cambridge Cognitive Examination, a widely accepted
and reliable screening tool [11]. Our results indicate that
the questions are capable of identifying individuals with
MMSE scores corresponding to early AD. In our opinion,
it is likely that the results are valid for western popula-
tions with similar demographics and co-morbidities.
It is known that GPs hesitate to diagnose mild cognitive
impairment or early stage of dementia [27]. Mild to mod-
erate cognitive impairment in the elderly, including early
stage AD, seems to be disregarded by both relatives and
health professionals, even though this stage of cognitive
Table 1: Demographic characteristics according to gender and recruitment method.
Total Routine Practice Screening p-value
Age Years (n)
All 80.7 ± 7.0 (187) 82.3 ± 6.1 (87) 79.5 ± 7.5 (100) = .006
Women 82.0 ± 6.5 (113) 83.0 ± 5.5 (67) 81.1 ± 7.5 (46) = .13
Men 78.8 ± 7.2 (74) 80.2 ± 7.5 (20) 78.2 ± 7.1 (54) = .29
p-value = .001 = .08 = .06
Gender, women n (%)
113 (60) 67 (77) 46 (46) < .001
MMSE score
All 23.0 ± 3.9 21.3 ± 4.2 24.4 ± 2.9 < .001*
Women 22.5 ± 3.9 21.2 ± 4.1 24.4 ± 2.7 < .001
Men 23.8 ± 3.7 21.8 ± 4.6 24.5 ± 3.0 = .004
p-value = .03† = .60 = .80
Marital status (living couple) n (%)
All 81 (43) 28 (32) 53 (53) = .004
Women 29 (26) 15 (22) 14 (30) = .34
Men 70 (52) 13 (65) 39 (72) = .40
p-value < .001§ = .001 < .001
Own house/compartment n (%)
All 141 (75) 54 (62) 87 (87) < .001
Women 77 (68) 41 (61) 36 (78) = .06
Men 64 (86) 13 (65) 51 (94) = .001
p-value = .004|| = .76 = .04
Support from community nurses n (%)
All 85 (47) 57 (66) 28 (28) < .001
Women 62 (55) 45 (67) 17 (37) = .002
Men 23 (32) 12 (60) 11 (21) = .001
p-value = .002.¶ = .55 = .08
The Northern Norwegian Dementia Study Group 2008.  *Adjusted for age, education, gender and co-morbidity p < .001. †Age-adjusted p = 
.17. §Age-adjusted p < .001. ||Age-adjusted p = .10. ¶Age-adjusted p = .04Andersen et al. BMC Medical Research Methodology 2010, 10:35
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impairment has the best response to intervention. In this
study, only one of five GPs in the nine municipalities
joined the pre-study educational program aimed to
improve AD diagnostics. Our findings are in accordance
with those of Vernooij-Dassen et al who reported that
GPs tend to postpone a comprehensive examination of
patients who complain of memory problems [28]. Lack of
therapeutic and diagnostic skills may contribute to this
attitude [27]. Carters et al described such insufficient
examination as a consequence of time constraints [29],
w h e r eas  W i l c oc k  e t  a l  r e po rt ed  t h a t  a  n u m be r  o f  G P s
considered studies aiming to diagnose and manage AD
irrelevant to their practice [30].
According to Norwegian recommendations, early stage
dementia and MCI should be diagnosed in memory clin-
ics and not in primary health care [31]. However, due to
shortage of memory clinics, this strategy will not benefit
the majority of elderly with early stage dementia. Under
these circumstances GPs have to be supported and
trained to detect and diagnose cognitive impairment.
Conclusions
Few AD studies have compared patient characteristics of
different recruitment methods. In our study patients
recruited by screening were younger, more frequently
men and had a higher MMSE sum score as compared to
those recruited from general practice. Screening of cogni-
tive function by questionnaires enables recruitment of
early stage AD, whereas general practice recruits patients
with more advanced disease. Future dementia studies on
prevention and treatment should take recruitment meth-
ods into consideration, in particular when focusing on
early stage AD. According to our experience, the applied
screening questionnaire, preceding a clinical examina-
tion, would be a suitable strategy to identify and diagnose
AD in primary health care.
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